Triamcinolone Intravitreal

Triamcinolone intravitreal is used for sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to ophthalmic corticosteroids. Triamcinolone intravitreal is also used for visualization during vitrectomy (Triesence).

Triamcinolone intravitreal is available under the following different brand names: Triesence and Trivaris Intravitreal.

Dosages of Triamcinolone Intravitreal:

Injectable Suspension, Intravitreal (as acetonide salt)

• 4mg/0.1mL

Dosage Considerations – Should be Given as Follows:

Ophthalmic Disease

• Indicated for sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to ophthalmic corticosteroids
• Initial: 4 mg intravitreal once; may administer additional doses as needed

Visualization During Vitrectomy (Triesence)

• 1-4 mg intravitreal

Side effects of triamcinolone_intravitreal topical include:

• Abnormal sensation in the eye
• Anterior chamber cells
• Anterior chamber flare
• Cataracts
• Conjunctival hemorrhage
• Exophthalmos
• Eye irritation
• Eye itching
• Eye pain
• Foreign body sensation in eyes
• Glaucoma
• Increased intraocular pressure
• Increased tearing
• Injection site hemorrhage
• Optic disc vascular disorder
• Pus in the eye (hypopyon)
• Vitreous detachment
• Vitreous floaters
• Rare instances of blindness associated with intravitreal or periocular injections

This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.

If your doctor has directed you to use this medication, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor, health care provider or pharmacist first.

• Triamcinolone Intravitreal has no listed severe interactions with other drugs.
• Triamcinolone Intravitreal has no listed serious interactions with other drugs.
• Triamcinolone Intravitreal has no listed moderate interactions with other drugs.
• Triamcinolone Intravitreal has no listed mild interactions with other drugs.

Warnings

• This medication contains triamcinolone intravitreal. Do not take Triesence or Trivaris Intravitreal if you are allergic to triamcinolone intravitreal or any ingredients contained in this drug.

Contraindications

• Hypersensitivity
• Idiopathic thrombocytopenic purpura
• Systemic fungal infections
• Cerebral malaria

Effects of Drug Abuse

• No information is available

Short-Term Effects

• See "What Are Side Effects Associated with Using Triamcinolone Intravitreal?"

Long-Term Effects

• Prolonged use may produce posterior subcapsular cataracts, glaucoma with possible damage to the optic nerves, and may enhance the establishment of secondary ocular infections due to fungi or viruses.
• Intraocular pressure (IOP) may become elevated in some individuals; if steroid therapy is continued for more than 6 weeks, IOP should be monitored
• See "What Are Side Effects Associated with Using Triamcinolone Intravitreal?"

Cautions

• Prolonged use may produce posterior subcapsular cataracts, glaucoma with possible damage to the optic nerves, and may enhance the establishment of secondary ocular infections due to fungi or viruses
• The use of oral corticosteroids is not recommended in the treatment of optic neuritis and may lead to an increase in the risk of new episodes
• Intraocular pressure (IOP) may become elevated in some individuals; if steroid therapy is continued for more than 6 weeks, IOP should be monitored
• Corticosteroids should be used cautiously in patients with a history of ocular herpes simplex because of possible corneal perforation; do NOT use in active ocular herpes simplex
• The rate of infectious culture-positive endophthalmitis is 0.5%; proper aseptic techniques should always be used when administering triamcinolone acetonide
• In addition, patients should be monitored following the injection to permit early treatment should an infection occur
• Children who are treated with corticosteroids by any route, including systemically administered corticosteroids, may experience a decrease in their growth velocity

Pregnancy and Lactation

• Use triamcinolone intravitreal during pregnancy only in LIFE-THREATENING emergencies when no safer drug is available. There is positive evidence of human fetal risk.
• Triamcinolone intravitreal is distributed in breast milk. Caution is advised while breastfeeding.